In this episode, Joe Moore interviews Brom Rector: podcaster and founder of Empath Ventures, a venture capital fund that invests in psychedelic medicine startups. Rector talks about which companies he sees succeeding, which companies are set up to fail, which he is investing in; and why the current crash (or lull) in psychedelic business is a good thing. He also discusses the theory of psychedelics damaging heart valves; the connection between Oprah, MDMA, and Mormons in UTAH; Xanax as a psychedelic security blanket; logical positivism; the DSM-5; Colorado Initiative 58; Mike Tyson; Compass Pathways; Christian Angermayer’s leaked memo; ibogaine; Dr. Zee and the next generation of Shulgins, and much, much more.
The post PT356 – Brom Rector – Investing in Psychedelics and The Rush to Improve on the Classics appeared first on Psychedelics Today.
